Disentangling the histological underpinnings of these imaging biomarkers, particularly by independently analyzing cortical thickness and area, could provide more specific insights into the therapeutic potential of targeting pathways such as BDNF/TrkB to ameliorate language impairment after stroke. The gene discussed is NTRK2; the disease is stroke disorder.